Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
Active & Responsive
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Fort Worth TX, Dallas TX, Houston TX, Westwood KS,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT06901531
Phase 3, Recruiting
Active & Responsive
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for
Castration Levels of Testosterone,
Location: Fort Worth TX, Dallas TX, Richardson TX,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT03678025
Phase 3, Recruiting
Active & Responsive
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Location: Fort Worth TX, Dallas TX, Richardson TX, Houston TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03816345
Phase 1, Recruiting
Active & Responsive
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia (ITP),
Location: Fort Worth TX, Fayetteville AR, Covington LA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07421167
Phase 2, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Fort Worth TX, Dallas TX, Forney TX, Denison TX,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)
for
Flexible Hammertoe, Semi-flexible Hammertoe
Location: Fort Worth TX, Bedford TX, Georgetown TX,
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
Sex: All
Age: 18 - 70+
Code: NCT07759362
Phase 3, Recruiting
Active & Responsive
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Fort Worth TX, Oklahoma City OK, San Antonio TX,
Sponsor: Ascendis Pharma A/S
Sex: All
Age: 2 - 17
Code: NCT07221851
Phase 3, Recruiting
Active & Responsive
Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer
for
Dementia
Location: Fort Worth TX
Sponsor: Texas Christian University
Sex: All
Age: 18+
Code: NCT07377331
Phase 1, Recruiting
Active & Responsive
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
for
Treatment-resistant Depression (TRD)
Location: Fort Worth TX, Irving TX, Dallas TX, Plano TX,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70+
Code: NCT07553637
Phase 2, Recruiting
Active & Responsive
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
for
Graves' Disease
Location: Fort Worth TX, Dallas TX, Conroe TX, Houston TX,
Sponsor: Yarrow Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT07682896
Phase 2, Recruiting
Active & Responsive
Study of ALK-001 on the Progression of Stargardt Disease
for
Stargardt Disease
Location: Fort Worth TX, Dallas TX, San Antonio TX, Aurora CO,
Sponsor: Alkeus Pharmaceuticals, Inc.
Sex: All
Age: 8 - 45
Code: NCT07419334
Phase 3, Recruiting
Active & Responsive
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
for
Schizophrenia
Location: Fort Worth TX, Oklahoma City OK, Stafford TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07379827
Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Fort Worth TX, Mansfield TX, Lewisville TX, Dallas TX,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase 3, Recruiting
Active & Responsive
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: North Richland Hills TX, DeSoto TX, McKinney TX,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase 3, Recruiting
Active & ResponsiveNew
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
for
Obesity, Overweight
Location: North Richland Hills TX, DeSoto TX, Dallas TX,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07871409
Phase 3, Recruiting
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: Fort Worth TX, Garland TX, Tyler TX, Cedar Park TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase 2, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
for
Chronic Kidney Disease
Location: Arlington TX, Minneapolis MN, South Salt Lake UT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07753993
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease